Navigation Links
Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
Date:5/13/2008

Loss before income

taxes (5,111,194) (6,721,168) (10,433,518) (22,425,359)

Income tax benefit - - 1,291,444 778,308

NET LOSS $(5,111,194) $(6,721,168) $(9,142,074) $(21,647,051)

Basic and diluted

net loss per

common share $(0.06) $(0.09) $(0.11) $(0.30)

Weighted average

number of common

shares outstanding

used in computing

basic and diluted

net loss per common

share 85,204,169 78,052,712 85,195,179 73,329,042

PALATIN TECHNOLOGIES, INC.

Consolidated Balance Sheets

(unaudited)

March 31, June 30,

2008 2007

ASSETS

Current assets:

Cash and cash equivalents $14,223,326 $31,447,615

Available-for-sale investments 3,385,752 2,323,642

Accounts receivable 338,870 607,841

Prepaid expenses and other current assets 707,261 1,008,464

Total current assets 18,655,209 35,387,562

Property and equipment, net 5,478,267 6,070,226

Restricted cash 475,000 475,000

Other assets 58,926 848,446

Total assets $24,867,402 $42,781,234

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Capital lease obligations and notes

payable, current portion $281,840 $216,841

Accounts payable 979,142 1,120,894

Accrued expenses
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
2. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
3. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
4. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
5. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
8. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
9. Veran Medical Technologies Secures $4.75M in First Institutional Funding
10. Neurobiological Technologies Reports Third Quarter Financial Results
11. InSet Technologies Appoints Jon Tremmel to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) announced today ... on its board of directors. Winger is ... years of experience in corporate management, financial and ... industry perspective at an important time in the ... CEO of Nektar and member of the Board ...
(Date:12/11/2009)... Dec. 11 EntreMed, Inc. (Nasdaq: ... million in royalty revenue from sales of Thalomid® ... revenue of $3.3 million. In addition, the ... projected revenue for fiscal 2009. The difference ... quarter will be reflected in the fourth quarter ...
(Date:12/11/2009)... HILL, MA (12/11/2009) Boston College researchers have observed ... the first time and successfully harvested the elusive charges ... improved solar power efficiency, the authors report in the ... , When light is captured in solar cells, it ... But in order to snare these charges, the electrons ...
(Date:12/11/2009)... Dec. 11 Gwathmey, Inc., a pre-clinical ... cancer, staph aureus, and cardiovascular disease announces a ... today that Rosalie Dunn, Ph.D., has joined Gwathmey ... over 28 years of experience working with small ... joining Gwathmey, Dr. Dunn managed multimillion dollar portfolios ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3EntreMed Reports Receipt of Third Quarter Royalty Payment 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... (Nasdaq: ALGN ) today announced that it ... Labour and Welfare (MHLW). The Company,may now begin ... has trained approximately 660 Invisalign orthodontists since launching the,product ... "This regulatory approval in Japan is an ...
... Prosolia, Inc. introduces a new,advanced Omni Spray Ion Source model ... 2-D Ion Source has an automated,surface platform which enables rapid ... 76 mm by 114 mm, which is the size of ... The Omni Spray 2-D Ion Source achieves a ...
... COUNTY, Calif., Dec. 8 Beckman Coulter,Inc. (NYSE: ... simplify, automate, and innovate complex biomedical tests, will host its,Annual ... December 16,2008, from 9:00 a.m. to 12:00 p.m. (ET). , ... ) , The live ...
Other Biology Technology:Align Technology Receives Expanded Regulatory Approval in Japan 2Prosolia to Introduce Omni Spray(R) Ion Source in 2-D Format 2
(Date:12/14/2009)... in preventing some of the stresses of open surgery on ... and organ dysfunction. Laparoscopy is a type of surgery in ... , By adding another gas to the carbon dioxide used ... University Medical Center have found they can preserve more normal ... nitrite (ENO) helped to open blood vessels and keep blood ...
(Date:12/13/2009)... that are associated with the health of the human ... scientists from 63 centres in Europe and Australia sheds ... , The new findings provide hope for better treatment ... and asthma. In the past it has been difficult ... affect the health of the lung are not completely ...
(Date:12/11/2009)... COWild Malus orientalis species of wild apples that ... to the Middle East and Central Asia. A new ... orientalis varieties from Georgia and Armenia with previously ... large population and establishes a core collection that will ... breeding and research communities. , To identify and record ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2Understanding apples' ancestors 2National Council on Agings Firman Lauds CLASS Act as Part of House Health Care Bill 60432 1National Council on Agings Firman Lauds CLASS Act as Part of House Health Care Bill 60432 2National Council on Agings Firman Lauds CLASS Act as Part of House Health Care Bill 60432 3Thermogenesis Corp to Announce First Quarter Fiscal 2010 Results on November 5 2009 14670 1Thermogenesis Corp to Announce First Quarter Fiscal 2010 Results on November 5 2009 14670 2Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation 5889 1Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation 5889 2Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation 5889 3
... team of researchers, including Kent State University professor Dr. ... the seasonal mass migration of Mormon crickets in western ... for protein and salt, and a fear of cannibalism, ... North America. , Throughout their seasonal migration, millions ...
... boosting anti-cancer drugs' effectiveness and lowering their toxicity by ... drugs. This extra weight makes the drugs penetrate and ... fall short of achieving their full impact because the ... rapidly, said the scientists from Duke University Medical Center ...
... future in which each patient's tumor will act like ... cancer to obtain the best outcome. , Currently, ... receive extra therapy after surgery - or whether some ... not even require surgery. Most patients with colorectal cancer ...
Other Biology News:Weighting cancer drugs to make them hit tumors harder 2Weighting cancer drugs to make them hit tumors harder 3Weighting cancer drugs to make them hit tumors harder 4Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 2Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 3Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 4Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 5Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 6Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 7
... economical ICS-90 uses continuous chemical suppression and ... you fast, accurate determinations of common anions ... to operate, quick to equilibrate, and fully ... ICS-90 helps you achieve maximum sample throughput ...
... 400 unique human proteins on a ... proteins, a cross section of all ... for high-quality results. Additional control proteins ... high validity and reproducibility., ,UNIchip protein ...
... UNIchip AV-400 contains 400 unique ... nitrocellulose-coated glass slide. The proteins, all ... Ontology classification, are arrayed in quadruplicate ... and a specific chip layout guarantee ...
... The Sub-Plates are E.Coli glycerol stocks contained ... contains 50 cDNA clones with approximately 5,000 ... the a master plate well, the corresponding ... PCR to identify the positive well(s). Cells ...
Biology Products: